Kate Krontz

Kate Krontz is a Senior Research Associate specializing in Clinical Immunology at Asklepios BioPharmaceutical, Inc. since April 2022, where responsibilities include supporting a Phase 2 trial evaluating AAV therapy for heart failure through advanced flow cytometry techniques. Prior experience includes roles as Senior Associate Scientist at Cambrex, focusing on method development and validation in a GMP environment, and Laboratory Research Technician III at Charles River Laboratories, leading drug discovery experiments. Kate also served as a Comparative Medicine Specialist at Duke University, caring for research animals. Educational background includes a Master’s Degree and Bachelor of Science in Animal Sciences from North Carolina State University.